Shortly after discovery of the ATRA-based therapy and the PML-RARα fusion protein, a second drug, namely arsenic trioxide (ATO), was also shown to cure APL, even as a single agent [122,123,124]. This evidence concerns the gene RARA and acute promyelocytic leukemia.